[Form 4] Lionsgate Studios Corp. Insider Trading Activity

Rhea-AI Filing Summary

Lionsgate Studios Corp. director reports new equity awards

A Lionsgate Studios Corp. director reported several equity-related transactions. On November 28, 2025, the director received an annual director equity award of 20,107 common shares at a price of $0, reflecting a stock-based grant. On the same date, the director also received 8,723 common shares as director fees paid in stock at a price of $7.46 per share. After these transactions, the director beneficially owned 409,085 common shares, which includes restricted share units scheduled to vest on November 29, 2025 and November 28, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SLOAN HARRY

(Last) (First) (Middle)

LIONSGATE

2700 COLORADO AVE.

(Street)

SANTA MONICA CA 90404

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lionsgate Studios Corp. [ LION ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	11/28/2025		A		20,107(1)	A	$0	400,362(2)	D
Common Shares	11/28/2025		A		8,723(3)	A	$7.46	409,085(2)	D
Common Shares	11/29/2025		F		0	D	$7.46	409,085(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual director equity award.

2. Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,370 restricted share units that are scheduled to vest on November 29, 2025; and (ii) 20,107 restricted share units that are scheduled to vest on November 28, 2026.

3. Director fees paid in common shares.

4. Amount includes 20,107 restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer, that are scheduled to vest on November 28, 2026.

Remarks:

	Harry Sloan (By Adrian Kuzycz by Power of Attorney)	12/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Lionsgate Studios Corp. (LION) report?

A director of Lionsgate Studios Corp. (LION) reported equity-related transactions, including an annual director equity award and director fees paid in common shares on November 28, 2025.

How many Lionsgate Studios Corp. (LION) shares were granted as the annual director equity award?

The annual director equity award consisted of 20,107 common shares of Lionsgate Studios Corp., reported at a price of $0 per share.

What director fees were paid in Lionsgate Studios Corp. (LION) stock?

The director received 8,723 common shares of Lionsgate Studios Corp. as director fees, at a price of $7.46 per share.

How many Lionsgate Studios Corp. (LION) shares does the director own after these transactions?

Following the reported transactions, the director beneficially owned 409,085 common shares of Lionsgate Studios Corp.

What restricted share units are included in the director’s Lionsgate Studios Corp. (LION) holdings?

The director’s holdings include restricted share units that are payable in an equal number of common shares and are scheduled to vest on November 29, 2025 and November 28, 2026, including a grant of 20,107 restricted share units vesting on November 28, 2026.

What is the director’s role at Lionsgate Studios Corp. (LION)?

The reporting person serves as a director of Lionsgate Studios Corp., as indicated by the relationship section of the filing.